1-Methyl-N-(3-{2-[(4-oxo-4H-chromen-7-yl)oxy]-acetamido}phenyl)-1H-pyrazole-3-carboxamide

ID: ALA4514074

PubChem CID: 155539166

Max Phase: Preclinical

Molecular Formula: C21H18N4O6S

Molecular Weight: 454.46

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cn1ccc(S(=O)(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)n1

Standard InChI:  InChI=1S/C21H18N4O6S/c1-25-9-7-21(23-25)32(28,29)24-15-4-2-3-14(11-15)22-20(27)13-31-16-5-6-17-18(26)8-10-30-19(17)12-16/h2-12,24H,13H2,1H3,(H,22,27)

Standard InChI Key:  QBTOASHKZHTING-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 32 35  0  0  0  0  0  0  0  0999 V2000
    6.3942   -6.3367    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1063   -6.7444    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    7.8144   -6.3367    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.5225   -6.7444    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5225   -7.5685    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2331   -7.9698    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9388   -7.5633    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9388   -6.7438    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6469   -6.3361    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.3549   -6.7438    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3549   -7.5633    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.0671   -6.3361    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7752   -6.7438    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.4833   -6.3361    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1957   -6.7463    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8998   -6.3332    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6081   -6.7401    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.3142   -6.3293    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3142   -5.5156    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6036   -5.1086    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6036   -4.2892    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.8998   -5.5195    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1892   -5.1075    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4833   -5.5166    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2305   -6.3371    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6935   -7.4543    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.5129   -7.4543    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.6476   -6.6680    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1001   -6.0629    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5074   -5.3511    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.3091   -5.5201    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.0998   -4.6431    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  4  3  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 22 20  1  0
 16 22  1  0
 22 23  2  0
 23 24  1  0
 24 14  2  0
  8 25  1  0
 25  4  2  0
  2 26  2  0
  2 27  2  0
 28  1  1  0
 28 29  2  0
 29 30  1  0
 30 31  1  0
 31  1  2  0
 30 32  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4514074

    ---

Associated Targets(Human)

ROCK1 Tclin Rho-associated protein kinase 1 (4723 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ROCK2 Tclin Rho-associated protein kinase 2 (6206 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 454.46Molecular Weight (Monoisotopic): 454.0947AlogP: 2.34#Rotatable Bonds: 7
Polar Surface Area: 132.53Molecular Species: ACIDHBA: 8HBD: 2
#RO5 Violations: HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 5.67CX Basic pKa: CX LogP: 1.93CX LogD: 1.05
Aromatic Rings: 4Heavy Atoms: 32QED Weighted: 0.44Np Likeness Score: -1.49

References

1. Zhao L, Li Y, Wang Y, Qiao Z, Miao Z, Yang J, Huang L, Tian C, Li L, Chen D, Yang S..  (2019)  Discovery of 4H-Chromen-4-one Derivatives as a New Class of Selective Rho Kinase (ROCK) Inhibitors, which Showed Potent Activity in ex Vivo Diabetic Retinopathy Models.,  62  (23): [PMID:31693351] [10.1021/acs.jmedchem.9b01143]

Source